Avanos Medical AVNS Earnings per common share - diluted (in dollars per share)
Earnings per common share - diluted (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's earnings per common share - diluted (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's earnings per common share - diluted (in dollars per share)?
- Avanos Medical (AVNS) reported earnings per common share - diluted (in dollars per share) of $0.11 in Q1 2026.
- How has Avanos Medical's earnings per common share - diluted (in dollars per share) changed year-over-year?
- Avanos Medical's earnings per common share - diluted (in dollars per share) decreased by 21.4% year-over-year, from $0.14 to $0.11.
- What is the long-term trend for Avanos Medical's earnings per common share - diluted (in dollars per share)?
- Over 3 years (2021 to 2025), Avanos Medical's earnings per common share - diluted (in dollars per share) has grown at a 129.4% compound annual growth rate (CAGR), from $0.13 to -$1.57.
- What does earnings per common share - diluted (in dollars per share) mean?
- Calculates the company's net income per share after accounting for the potential dilution from all outstanding equity-based instruments. It is the standard measure used by analysts to evaluate the company's earnings performance relative to its total potential share count.